Pharmaceutical Marketing authorization holders in the Netherlands are obliged to include information about the in-use shelf-life of OTC medicinal products in the product information. As a marketing authorization holder, the company must have stated to the Dutch Medicines Evaluation Board (MEB) no later than September 30, 2017 how it intends to comply with this policy in respect of OTC medicinal products. 18 September 2017